SCHEMBL30501365

SCHEMBL30501365

O=C(Nc1cnc(N2CCOCC2)cc1N1CCCCC1)c1cccc(Br)n1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 13/20 0.50
▸ PIM1 P11309 1/20 0.47
▸ PIM3 Q86V86 1/20 0.47
▸ IRAK1 P51617 1/20 0.46
▸ KIF18A Q8NI77 1/20 0.45
▸ TSHR P16473 2/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ POLB P06746 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ ALOX15 P16050 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ NTRK1 P04629 1/20 0.42
▸ NTRK2 Q16620 1/20 0.42
▸ BACE1 P56817 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20598489 1.00 IRAK4 (0.50) IRAK4PIM1PIM3IRAK1KIF18A
SCHEMBL30501448 0.84 NTRK1 (0.57) IRAK4PIM1PIM3IRAK1TSHR
SCHEMBL20598735 0.84 NTRK1 (0.57) IRAK4PIM1PIM3IRAK1TSHR
SCHEMBL20598394 0.83 PIM1 (0.53) IRAK4PIM1PIM3IRAK1TSHR
SCHEMBL20598482 0.82 PIM1 (0.51) IRAK4PIM1PIM3IRAK1TSHR
SCHEMBL30501501 0.82 PIM1 (0.51) IRAK4PIM1PIM3IRAK1TSHR
SCHEMBL20598608 0.82 IRAK4 (0.71) IRAK4PIM1PIM3IRAK1KIF18A
SCHEMBL28383371 0.82 PIM1 (0.55) IRAK4PIM1PIM3TSHRALDH1A1
SCHEMBL20598769 0.80 ALDH1A1 (0.61) TSHRALDH1A1NPSR1CYP1A2POLB
SCHEMBL20598682 0.80 TSHR (0.49) IRAK4PIM1PIM3TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111032642-B Kinase inhibitors and methods of making and using the same 里格尔药品股份有限公司 2023-07-18 — — CN disclosed
Send feedback